Epalrestat
Product Specifications
CAS Number
82159-09-9
Target
Reductase
Related Pathways
Endocrinology/Hormones, Metabolism
Purity
0.9954
Bioactivity
Epalrestat (ONO2235), an aldose reductase inhibitor, is well tolerated in Long-term therapy. It can effectually ameliorate the associated symptoms of diabetic neuropathy and delay the progression of the disease, particularly in patients with limited microangiopathy and good glycemic control.
Smiles
CC(=C/C1=CC=CC=C1)\C=C1/SC(=S)N(CC(O)=O)C1=O
Molecular Formula
C15H13NO3S2
Molecular Weight
319.4
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-1206R-PE-Cy5-TR 20 µL
GLI1 Polyclonal Antibody, PE-Cy5 Conjugated
Sign In for Pricing
View Details 
168690-AF-PE 100 µL
CD33 (gp67, My9, Myeloid cell surface antigen CD33, p67, Sialic acid-binding Ig-like lectin 3 (Siglec 3) ) (PE)
Sign In for Pricing
View Details